Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06888193 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Study acronym: BE CARING
StatusRecruiting
PhasePhase 1
Started2025-11-05
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later May 3, 2027 → Dec 31, 2027
See other at-risk trials from UCB Biopharma SRL

Amendment history

2026-09-19
critical
Primary completion pushed: 2027-05-03 → 2027-12-31
Completion pushed: 2027-05-03 → 2027-12-31
2026-07-16
minor
Study Status, Contacts/Locations v14
Study sites12→14
2026-04-30
minor
Study Status, Contacts/Locations v13
Study sites11→12
2026-04-02
minor
Study Status, Contacts/Locations v12
Study sites10→11
2026-01-22
minor
Study Status, Contacts/Locations v11
Study sites8→10
Show 10 earlier versions
2025-12-24
minor
Study Status, Contacts/Locations v10
Study sites7→8
2025-12-11
minor
Study Status, Contacts/Locations v9
Study sites6→7
2025-11-27
minor
Study Status, Contacts/Locations v8
Start dateestimated 2025-10→confirmed 2025-11-05
Study sites1→6
2025-09-25
minor
Study Status v7
Start date2025-09→2025-10
2025-09-18
minor
Study Status v6
Start date2025-08→2025-09
2025-08-19
minor
Study Status v5
Start date2025-07-31→2025-08
2025-06-26
minor
Study Status v4
Start date2025-06-15→2025-07-31
2025-06-06
minor
Study Status v3
Start date2025-05-30→2025-06-15
2025-05-16
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2026-11-16→2027-05-03
Completion date2026-11-16→2027-05-03
Start date2025-05-16→2025-05-30
Study sites0→1
2025-04-29
minor
Study Status v1
Start date2025-04-07→2025-05-16
2025-03-15
minor
Original filing
418 trials monitored
See 17 trials at risk
and 1 more disease
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
Trial Details
NCT Number NCT06888193
Lead Sponsor UCB Biopharma SRL
Conditions Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, Hidradenitis Suppurativa
Enrollment 20 participants
Start Date 2025-11-05
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-18